Cargando…
A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer
OBJECTIVE: We performed this meta-analysis to compare the efficacy and toxicity of regorafenib and TAS-102. METHODS: Electronic databases were searched to identify studies comparing the efficacy and safety of regorafenib and TAS-102 in patients with chemotherapy-refractory metastatic colorectal canc...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361493/ https://www.ncbi.nlm.nih.gov/pubmed/32660291 http://dx.doi.org/10.1177/0300060520926408 |